CAMSAP2

Across TCGA pan-cancer cohorts, CAMSAP2 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated CAMSAP2 data layer compared with 25 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher CAMSAP2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CAMSAP2 expression acts as an unfavorable survival marker, although some lineages such as UCEC and LUAD show a favorable association.

ESCA, UCEC, and SKCM are the cancer types where CAMSAP2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	III,IV	0.074	0.574	<.001	24	view →
UCEC	DFS	Median	All	0.931	0.610	.006	14	view →
SKCM	OS	Median	III,IV	0.138	0.841	<.001	8	view →
LUAD	DFS	Median	II,III,IV	1.000	0.225	.021	5	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CAMSAP2–ESCA (OS)

Open the ESCA breakdown →